Trial Profile
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Pegvisomant (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- 02 Feb 2016 New trial record